Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DARE | AZN | AMGN | GILD | BMY |
| Company | Dare Bioscience Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.27 | 202.81 | 351.90 | 138.95 | 59.20 |
| High | 3.43 | 205.20 | 356.28 | 139.76 | 60.48 |
| Low | 2.80 | 202.55 | 349.42 | 136.69 | 58.54 |
| Latest | 2.68 | 204.92 | 355.36 | 137.87 | 60.35 |
| Change | -0.04 | +4.45 | +5.97 | -0.68 | +1.39 |
| % Change | -1.47% | +2.22% | +1.71% | -0.49% | +2.36% |
| Volume | 8,791,187 | 862,543 | 1,450,633 | 2,966,627 | 5,970,712 |
| 20-Day Average Volume | 697,691 | 1,890,566 | 2,690,848 | 5,657,515 | 12,517,701 |
| Previous Close | 2.72 | 200.47 | 349.39 | 138.55 | 58.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.79 | 196.90 | 349.84 | 138.75 | 58.90 |
| 20-Day Raw Stochastic | 75.81% | 91.15% | 83.82% | 43.72% | 64.50% |
| 20-Day Relative Strength | 79.34 | 58.52 | 50.52 | 45.38 | 54.17 |
| Weighted Alpha | -27.81 | +48.35 | +26.86 | +31.63 | +30.88 |
| Today's Opinion | 8% Buy | 88% Buy | 56% Buy | 40% Buy | 80% Buy |
| Previous Opinion | 8% Buy | 88% Buy | 40% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 56% Buy | 80% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +58.47% since 04/10/26 | +0.52% since 04/10/26 | +1.28% since 04/10/26 | -0.81% since 04/10/26 | +2.65% since 04/10/26 |
| Low | 1.72 on 04/15/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 136.98 on 04/17/26 | 57.22 on 04/15/26 |
| High | 3.42 on 04/17/26 | 205.18 on 04/17/26 | 356.28 on 04/17/26 | 141.40 on 04/14/26 | 60.47 on 04/17/26 |
| 1-Month | |||||
| %Chg | +100.00% since 03/17/26 | +7.22% since 03/17/26 | -1.56% since 03/17/26 | -4.53% since 03/17/26 | +0.78% since 03/17/26 |
| Low | 1.27 on 03/20/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 3.42 on 04/17/26 | 207.30 on 04/10/26 | 360.68 on 03/18/26 | 143.79 on 03/18/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +50.26% since 01/16/26 | +8.64% since 01/16/26 | +7.59% since 01/16/26 | +10.37% since 01/16/26 | +8.89% since 01/16/26 |
| Low | 1.27 on 03/20/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 53.54 on 01/21/26 |
| High | 3.42 on 04/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +42.86% since 10/17/25 | +21.09% since 10/17/25 | +18.97% since 10/17/25 | +12.25% since 10/17/25 | +37.92% since 10/17/25 |
| Low | 1.27 on 03/20/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 3.42 on 04/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 39,603 | 310,910,528 | 188,560,544 | 171,971,328 | 120,380,688 |
| Shares Outstanding, K | 14,560 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 1,030,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -13,400,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,020,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,440,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.90 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/26/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/12/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.97 | 15.94 | 17.15 | 9.41 |